Facio-Scapulo-Humeral Dystrophy Clinical Trial
Official title:
A Phase1/2a Dose-Escalating Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ARO-DUX4 in Adult Patients With Facioscapulohumeral Muscular Dystrophy Type 1
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of ARO-DUX4 in participants with facioscapulohumeral muscular dystrophy Type 1 (FSHD1). In Part 1 of the study, participants will receive a single dose of ARO-DUX4 or placebo. In Part 2 of the study, participants will receive 2 or 4 doses of ARO-DUX4 or placebo. Participants who complete Part 1 will have the option to re-screen and re-randomize into Part 2. All participants will undergo pre- and post-dose MRI-guided muscle biopsies (a total of 2 biopsies). Participants who complete Part 1 and enroll in Part 2 will be required to undergo an additional screening biopsy. Participants completing Part 1 or Part 2 may have the option to continue to receive drug in an open-label extension study or may be eligible to participate in later-stage clinical studies.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02948244 -
Effect of Creatine Monohydrate on Functional Muscle Strength in Children With FSHD
|
N/A | |
| Completed |
NCT05022355 -
Examination of Operative Approach in pwFSHD (Patient With Facioscapulohumeral Muscular Dystrophy)
|
||
| Recruiting |
NCT06096441 -
FSHD Molecular Characterization
|
||
| Completed |
NCT04377217 -
Computerized Facial Recognition for Automated Diagnosis of the Facio-Scapulo-Humeral Muscular Dystrophy (FSMHD)
|
N/A | |
| Completed |
NCT05239520 -
Understanding Control and Mechanisms of Shoulder Instability in FSHD
|
||
| Recruiting |
NCT06378203 -
Rehabilitation in Muscular Dystrophies From the Hospital Facility to the Home: Pilot Project [RIMUDI]
|
N/A | |
| Recruiting |
NCT05747924 -
Phase 1/2 Study of AOC 1020 in Adults With Facioscapulohumeral Muscular Dystrophy (FSHD)
|
Phase 1/Phase 2 |